Literature DB >> 21353641

Time to detection of Mycobacterium tuberculosis as an alternative to quantitative cultures.

C M Bark1, A Okwera, M L Joloba, B A Thiel, J G Nakibali, S M Debanne, W H Boom, K D Eisenach, J L Johnson.   

Abstract

Testing new drugs is critical to improving the treatment of tuberculosis. Quantitative cultures of Mycobacterium tuberculosis on solid media have been used in Phase 1 and 2 trials, but are time and resource intensive. Time to detection (TTD) of growth of M. tuberculosis in automated liquid culture systems is an alternative. TTD has been shown to correlate with CFU in quantitative cultures, and is faster and simpler to perform. We compared TTD in the BACTEC 460 liquid culture system with CFU in a clinical trial that included 110 subjects. Comparing all sputum cultures collected between baseline and 2 months we found a strong negative correlation between log(10) CFU and TTD (rho = -0.91). In addition, when TTD at baseline was compared with 1 and 2 month sputum culture positivity, subjects whose cultures were negative after 1 and 2 months had a significantly longer median baseline TTD compared with subjects whose cultures were positive at 1 and 2 months (5 vs. 3 days and 3 vs. 2 days, respectively). TTD compares closely with CFU and represents a faster, simpler alternative to quantitative cultures.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21353641      PMCID: PMC4108903          DOI: 10.1016/j.tube.2011.01.004

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  11 in total

1.  Time to detection of the growth of Mycobacterium tuberculosis in MGIT 960 for determining the early bactericidal activity of antituberculosis agents.

Authors:  A H Diacon; J S Maritz; A Venter; P D van Helden; K Andries; D F McNeeley; P R Donald
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-09-04       Impact factor: 3.267

2.  Early bactericidal activity and pharmacokinetics of PA-824 in smear-positive tuberculosis patients.

Authors:  Andreas H Diacon; Rodney Dawson; Madeleine Hanekom; Kim Narunsky; Stefan J Maritz; Amour Venter; Peter R Donald; Christo van Niekerk; Karl Whitney; Doris J Rouse; Martino W Laurenzi; Ann M Ginsberg; Melvin K Spigelman
Journal:  Antimicrob Agents Chemother       Date:  2010-05-24       Impact factor: 5.191

3.  Evaluation of time to detection of Mycobacterium tuberculosis in broth culture as a determinant for end points in treatment trials.

Authors:  Marc Weiner; Thomas J Prihoda; William Burman; John L Johnson; Stefan Goldberg; Nesri Padayatchi; Paula Duran; Melissa Engle; Grace Muzanye; Roy D Mugerwa; A Willem Sturm
Journal:  J Clin Microbiol       Date:  2010-10-06       Impact factor: 5.948

4.  Baseline sputum time to detection predicts month two culture conversion and relapse in non-HIV-infected patients.

Authors:  A C Hesseling; G Walzl; D A Enarson; N M Carroll; K Duncan; P T Lukey; C Lombard; P R Donald; K A Lawrence; R P Gie; P D van Helden; N Beyers
Journal:  Int J Tuberc Lung Dis       Date:  2010-05       Impact factor: 2.373

5.  Randomized trial of adjunctive interleukin-2 in adults with pulmonary tuberculosis.

Authors:  John L Johnson; Emmanuel Ssekasanvu; Alphonse Okwera; Harriet Mayanja; Christina S Hirsch; Joseph G Nakibali; Dana Drzayich Jankus; Kathleen D Eisenach; W Henry Boom; Jerrold J Ellner; Roy D Mugerwa
Journal:  Am J Respir Crit Care Med       Date:  2003-04-17       Impact factor: 21.405

6.  Quantitative sputum bacillary load during rifampin-containing short course chemotherapy in human immunodeficiency virus-infected and non-infected adults with pulmonary tuberculosis.

Authors:  M L Joloba; J L Johnson; A Namale; A Morrissey; A E Assegghai; R D Mugerwa; J J Ellner; K D Eisenach
Journal:  Int J Tuberc Lung Dis       Date:  2000-06       Impact factor: 2.373

7.  Predicting the outcome of therapy for pulmonary tuberculosis.

Authors:  R S Wallis; M D Perkins; M Phillips; M Joloba; A Namale; J L Johnson; C C Whalen; L Teixeira; B Demchuk; R Dietze; R D Mugerwa; K Eisenach; J J Ellner
Journal:  Am J Respir Crit Care Med       Date:  2000-04       Impact factor: 21.405

8.  Rapid radiometric methods to detect and differentiate Mycobacterium tuberculosis/M. bovis from other mycobacterial species.

Authors:  S H Siddiqi; C C Hwangbo; V Silcox; R C Good; D E Snider; G Middlebrook
Journal:  Am Rev Respir Dis       Date:  1984-10

9.  Time to detection of Mycobacterium tuberculosis in BACTEC systems as a viable alternative to colony counting.

Authors:  C Pheiffer; N M Carroll; N Beyers; P Donald; K Duncan; P Uys; P van Helden
Journal:  Int J Tuberc Lung Dis       Date:  2008-07       Impact factor: 2.373

10.  Drug tolerance in Mycobacterium tuberculosis.

Authors:  R S Wallis; S Patil; S H Cheon; K Edmonds; M Phillips; M D Perkins; M Joloba; A Namale; J L Johnson; L Teixeira; R Dietze; S Siddiqi; R D Mugerwa; K Eisenach; J J Ellner
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

View more
  17 in total

1.  Pretreatment time to detection of Mycobacterium tuberculosis in liquid culture is associated with relapse after therapy.

Authors:  Charles M Bark; Bonnie A Thiel; John L Johnson
Journal:  J Clin Microbiol       Date:  2011-11-23       Impact factor: 5.948

2.  A multisite assessment of the quantitative capabilities of the Xpert MTB/RIF assay.

Authors:  Robert Blakemore; Pamela Nabeta; Amy L Davidow; Viral Vadwai; Rasim Tahirli; Vanisha Munsamy; Mark Nicol; Martin Jones; David H Persing; Doris Hillemann; Sabine Ruesch-Gerdes; Felicity Leisegang; Carlos Zamudio; Camilla Rodrigues; Catharina C Boehme; Mark D Perkins; David Alland
Journal:  Am J Respir Crit Care Med       Date:  2011-11-01       Impact factor: 21.405

3.  Time to detection of Mycobacterium tuberculosis using the MGIT 320 system correlates with colony counting in preclinical testing of new vaccines.

Authors:  K Kolibab; A Yang; M Parra; S C Derrick; S L Morris
Journal:  Clin Vaccine Immunol       Date:  2013-12-26

4.  Dynamic population changes in Mycobacterium tuberculosis during acquisition and fixation of drug resistance in patients.

Authors:  Gang Sun; Tao Luo; Chongguang Yang; Xinran Dong; Jing Li; Yongqiang Zhu; Huajun Zheng; Weidong Tian; Shengyue Wang; Clifton E Barry; Jian Mei; Qian Gao
Journal:  J Infect Dis       Date:  2012-09-14       Impact factor: 5.226

Review 5.  Challenges in the clinical assessment of novel tuberculosis drugs.

Authors:  Kelly E Dooley; Patrick P J Phillips; Payam Nahid; Michael Hoelscher
Journal:  Adv Drug Deliv Rev       Date:  2016-01-28       Impact factor: 15.470

6.  Rapid DNA extraction for specific detection and quantitation of Mycobacterium tuberculosis DNA in sputum specimens using Taqman assays.

Authors:  Diana I Gomez; Caroline S Mullin; Francisco Mora-Guzmán; J Gonzalo Crespo-Solis; Susan P Fisher-Hoch; Joseph B McCormick; Blanca I Restrepo
Journal:  Tuberculosis (Edinb)       Date:  2011-11-15       Impact factor: 2.973

7.  Chest Radiographic Patterns and the Transmission of Tuberculosis: Implications for Automated Systems.

Authors:  Angela Lau; James Barrie; Christopher Winter; Abdel-Halim Elamy; Gregory Tyrrell; Richard Long
Journal:  PLoS One       Date:  2016-04-22       Impact factor: 3.240

8.  PCR to detect Mycobacterium tuberculosis in respiratory tract samples: evaluation of clinical data.

Authors:  F P Rozales; A B M P Machado; F De Paris; A P Zavascki; A L Barth
Journal:  Epidemiol Infect       Date:  2013-10-10       Impact factor: 4.434

9.  Time to culture positivity and sputum smear microscopy during tuberculosis therapy.

Authors:  Ioana D Olaru; Jan Heyckendorf; Susanne Grossmann; Christoph Lange
Journal:  PLoS One       Date:  2014-08-29       Impact factor: 3.240

10.  Performance evaluation of three commercial molecular assays for the detection of Mycobacterium tuberculosis from clinical specimens in a high TB-HIV-burden setting.

Authors:  M M Z Matabane; F Ismail; K A Strydom; O Onwuegbuna; S V Omar; N Ismail
Journal:  BMC Infect Dis       Date:  2015-11-09       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.